Atgal į konkursus

Biologiniai vaistai II

Atviras
Galutinis terminas
Liko 10 dienų
Kovas 13, 2026
Informacija apie sutartį
Kategorija
Tiekimas
Nuoroda
305811
Vertė
€235,000
Vieta
Estonia, Estija
Paskelbta
Vasaris 12, 2026
CPV kodas
Vertinimo kriterijai
Bid cost100%
Projekto grafikas

Konkursas paskelbtas

Vasaris 12, 2026

Klausimų pateikimo terminas

Kovas 06, 2026

Pasiūlymų pateikimo terminas

Kovas 13, 2026

Konkurso atidarymas

Kovas 13, 2026

Laimėjimo tikimybėPRO
🔒
Atnaujinti į Professional
Peržiūrėkite savo apskaičiuotą laimėjimo tikimybę pagal istorinius duomenis.
Atnaujinti į Professional →
Pirkėjo analitikaPRO
🔒
Atrakinkite pirkėjo analitiką
Peržiūrėkite išlaidų modelius, pageidaujamas procedūras ir kita.
Atnaujinti į Professional →
Sektoriaus įžvalgosPRO
🔒
Atrakinkite sektoriaus įžvalgas
Peržiūrėkite vidutines laimėjimo kainas, konkurencijos lygius ir rinkos tendencijas.
Atnaujinti į Professional →
Biudžetas
€235,000
Trukmė
Nenurodyta
Vieta
Estonia
Tipas
Tiekimas
83
Kokybės įvertinimas/100
Puikiai
Rinkos lyginamoji analizė
Vidutinė laimėjimo kaina
€92,792
Vidutinis pasiūlymų skaičius
2.2
Konkurencija
Žema
MVĮ laimėtojai
86%
3,220 išanalizuotų pirkimų skaičius

Originalus konkurso aprašymas

Viešojo pirkimo tikslas – sudaryti pagrindinę sutartį biologiniams vaistams įsigyti. Detalesnis viešojo pirkimo objekto aprašymas pateikiamas dokumente „1 priedas. Techninė specifikacija“. Viešojo pirkimo rezultatu kiekvienai viešojo pirkimo daliai bus sudaryta pagrindinė sutartis su vienu tiekėju 12 mėnesiams. Atskiri sutartys nebus pasirašomos remiantis pagrindine sutartimi, o pagrindinė sutartis bus vykdoma pagal užsakymus. Pasiūlyme pateikta vaisto vieneto kaina galioja visą pagrindinės sutarties galiojimo laikotarpį.
Elektroninis pateikimas

Rizikos analizė

Prisijunkite, kad galėtumėte naudoti rizikos analizę.

Prisijungti

Laimėjimo strategija

Prisijunkite, kad galėtumėte naudoti laimėjimo strategijos rekomendacijas.

Prisijungti

Konkurentai

Atnaujinkite, kad matytumėte, kurios įmonės greičiausiai pateiks pasiūlymą šiam konkursui, remiantis istoriniais viešųjų pirkimų duomenimis.

Prisijungti

Reikalavimai ir kvalifikacija

16 reikalavimų 5 kategorijose

Pateikimas (6)
Privalomas (1)
Atitiktis (3)
Techninis (3)
Finansinis (3)
SUBMISSION REQUIREMENTS6
--Submit a completed European Single Procurement Document (ESPD).
--For joint bidders, a power of attorney must be submitted.
--Follow the procedure for declaring business secrets.
MANDATORY EXCLUSION GROUNDS1
--The bidder must not have any grounds for exclusion established by the contracting authority, as described in the ESPD.
ELIGIBILITY REQUIREMENTS3
--The bidder must fulfill the qualification conditions established by the contracting authority, as described in the ESPD.
--The bidder must comply with EU sanctions against the Russian Federation.
--If the bidder relies on the resources of another entity to meet qualification criteria, that entity must provide consent and commit to fulfilling the relevant contractual obligations.
TECHNICAL CAPABILITY REQUIREMENTS3
--The offered biological medicines must comply with the technical specifications, including active ingredients, pharmaceutical forms, strengths, and packaging, as stipulated in the Technical Description (Annex 1).
--Delivery conditions must meet the requirements, including transport, original packaging, and minimum shelf life, as described in the Technical Description (Annex 1).
--Technical specifications for the offered biological medicines must be submitted using Form Annex 3.
FINANCIAL REQUIREMENTS3
--The bid price (excluding VAT) is the sole evaluation criterion, with the lowest price receiving the maximum score.
--The bidder must accept the payment terms described in the draft framework agreement (Annex 2).
--Unit prices must be submitted excluding VAT and must be valid for the entire contract period, using Form Annex 3.

Reikalavimų peržiūra

Prisiregistruokite, kad peržiūrėtumėte visus reikalavimus ir analizę

Dokumentai

Yra 9 dokumentų su AI santraukomis

VastavustingimusedPDF
305811_vastavustingimused.pdf -- 17.3 KB

This document outlines tender compliance conditions, including adherence to EU sanctions against the Russian Federation, the requirement for a joint bidders' authorization if applicable, and procedures for declaring business secrets.

Lisa 3. Pakutavate kaupade spetsifikatsioon ja maksumuse vormXLS
Lisa 3 Pakutavate kaupade spetsifikatsioon ja... -- 12.0 KB

This document is a form where bidders must provide the technical specifications and VAT-exclusive unit prices of the biological medicines offered, which will be valid throughout the contract period.

Hindamiskriteeriumid ja hinnatavad näitajadPDF
305811_hindamiskriteeriumid.pdf -- 7.2 KB

This document details the tender evaluation methodology, specifying that the bid cost (excluding VAT) is the sole criterion, with the lowest price receiving the maximum points.

Hankepass täiendatavate selgitustegaPDF
305811_hankepass_taiendavate_selgitustega.pdf -- 63.9 KB

This document is an explanatory Hankepass (ESPD) outlining the contracting authority's qualification conditions and exclusion grounds, intended for review rather than direct submission.

Juhend pakkujaleDOC
Juhend pakkujale.docx -- 44.8 KB

This document is a guide for tenderers participating in the open procurement procedure "Biological medicines II," outlining the tender parts and estimated costs.

Lisa 1. Tehniline kirjeldusDOC
Lisa 1 Tehniline kirjeldus.docx -- 33.6 KB

This document outlines the technical specifications for biological medicines, including active ingredients, dosage forms, strengths, and packaging, along with delivery conditions such as transport, original packaging, and minimum shelf life.

Lisa 2. Raamlepingu projektDOC
Lisa 2 Raamlepingu projekt.docx -- 30.3 KB

This is a draft framework agreement for the sale and transport of biological medicines, detailing the contract's subject, validity, and payment terms, providing an overview of future contractual obligations.

Lisa 4. Ühispakkujate volikiriDOC
Lisa 4 Ühispakkujate volikiri.docx -- 18.5 KB

This document is a power of attorney template for joint tenderers, outlining their joint and several liability and authorizing one partner to submit the tender and manage the resulting contract on behalf of the consortium.

Lisa 5. Teise ettevõtja nõusolek tema vahenditele tuginemiseksDOC
Lisa 5 Teise ettevõtja nõusolek tema vahendit... -- 17.8 KB

This document is a consent form where a third party confirms that the tenderer may rely on its resources to meet the qualification conditions for the "Bioloogilised ravimid II" public procurement and commits to fulfilling the relevant contractual obligations.

Dokumentų peržiūra

Prisiregistruokite, kad peržiūrėtumėte dokumentų santraukas ir analizę

83
Puikiai

Konkurso kokybės įvertinimas

This tender for biological medicines is well-structured and clear, demonstrating strong legal compliance and fairness through transparent criteria and e-procurement. While comprehensive, it lacks explicit sustainability considerations and has minor data inconsistencies.

Įvertinimo detalės

Atitiktis teisės aktams85/100

The tender appears largely compliant with national and EU regulations, clearly defining the procedure type and CPV codes. Deadlines are reasonable, and EU sanctions compliance is explicitly required. The 'Negotiation Allowed' characteristic for an 'A' (Open) procedure is a minor ambiguity, as open procedures are typically non-negotiable.

The characteristic 'Negotiation Allowed' is listed for an 'A' (Open) procedure, which is typically non-negotiable, creating a minor procedural ambiguity.
Aiškumas90/100

The tender description is clear, and requirements are well-documented across various annexes. Evaluation criteria (lowest price) and performance conditions are explicitly stated, making the tender easy to understand for potential bidders. AI-extracted requirements are comprehensive and accurate.

Užbaigtumas85/100

All essential information, including title, organization, reference, estimated value, and duration (12 months for the framework agreement), is provided. The tender includes 10 relevant documents detailing technical specifications, contract terms, and submission forms. The NUTS code is missing, which is a minor omission.

NUTS code is not provided.
Sąžiningumas90/100

The tender promotes fairness through a disclosed estimated value, reasonable submission deadlines, and objective evaluation criteria (lowest price). E-procurement is enabled, ensuring equal access, and requirements appear generic, not tailored to a specific company.

Praktiškumas80/100

Electronic submission and e-procurement are fully supported, enhancing practicality. Financing information and duration are specified within the documents. The exact contract start date is not explicitly stated but is typically determined upon award.

The exact contract start date is not explicitly stated.
Duomenų nuoseklumas85/100

Key fields are mostly populated, and dates are logical. There are no reported disputes or suspensions. The minor inconsistency regarding 'Negotiation Allowed' for an 'A' procedure and the 'Value Classified: Yes' alongside a disclosed estimated value are noted but do not significantly hinder overall consistency.

Minor inconsistency between 'Procedure: A' (Open) and 'Negotiation Allowed' characteristic.
Slight ambiguity with 'Value Classified: Yes' despite an estimated value being disclosed.
Tvarumas30/100

The tender does not explicitly incorporate green procurement, social aspects, or innovation focus. While this is common for medical supplies where product efficacy and safety are paramount, it represents a missed opportunity to align with broader sustainability goals.

No explicit sustainability criteria (green, social, innovation) are included.

Privalumai

Clear and comprehensive requirements with detailed annexes.
Objective and transparent evaluation criteria (lowest price).
Full support for electronic submission and e-procurement.
Reasonable submission deadline and disclosed estimated value.
Compliance with EU sanctions explicitly required.

Problemos

Lack of explicit sustainability, social, or innovation criteria.
Minor inconsistency regarding 'Negotiation Allowed' for an 'A' (Open) procedure.
NUTS code is missing from the basic information.
The exact contract start date is not explicitly stated.

Rekomendacijos

1. Consider integrating sustainability criteria, such as environmentally friendly packaging or ethical sourcing, where applicable for biological medicines.
2. Clarify the 'Negotiation Allowed' characteristic in relation to the 'A' (Open) procedure type to avoid potential misinterpretations.
3. Provide the NUTS code for better geographical classification.

AI įvertinimo peržiūra

Prisiregistruokite, kad peržiūrėtumėte visus reikalavimus ir analizę

Išsami kokybės balo analizė
Detali sub-balų analizė
Privalumų ir trūkumų įžvalgos
Strateginės rekomendacijos

Nereikia kreditinės kortelės • Sąranka per 2 minutes

Įtraukti į „Pipeline“